SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
213waiting to hear: 4Q05: ACP-103 final results from phase II akathisia trial in smopgcw-1/7/2006
212we have a sleep expert....... Message 22031428 :-)scaram(o)uche-1/5/2006
211ACADIA Pharmaceuticals Discovers Novel Isoform-Selective Retinoic Acid Receptor scaram(o)uche-12/15/2005
210Just now, ACAD puts out a press release about these RAR2B compounds. PubCrawlertuck-12/15/2005
209Only if you're British... ?nigel bates-12/8/2005
208Creativity tied to sexual 'success' By Amy Norton news.yahoo.com NEW scaram(o)uche-12/7/2005
207[Plasma clozapine levels and clinical response in treatment-refractory Chinese stuck-12/4/2005
206two...... 1. good enough to be enthusiastic. 2. silly to say that an endpoinscaram(o)uche-12/1/2005
205Any reaction? Appreciate it. georgemopgcw-12/1/2005
204ACADIA Pharmaceuticals Reports Results From Phase II Study of ACP-103 in Schizopscaram(o)uche-12/1/2005
203[Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid betuck-11/24/2005
202[Identification of novel subtype selective RAR agonists] >>Biochem Pharmatuck-11/24/2005
201Br J Pharmacol. 2005 Nov 14; [Epub ahead of print] Characterization of the Masscaram(o)uche-11/17/2005
200Ken... no short-term memory, sorry. I heard it just recently, too. >> scaram(o)uche-11/10/2005
199Hi Rick... up to a 100mg. If you know off the top of your head... what is the ekenhott-11/10/2005
198ACADIA Pharmaceuticals Announces Initial Results From Ongoing Single-Dose Clinicscaram(o)uche-11/10/2005
197The Motley Fool site included Acadia in their story, "A $99 Biotech Portfoljaspersg-11/7/2005
196>> Do you think Brann might be next? << I think that you're an scaram(o)uche-11/4/2005
195Your posting made me do a little homework. Turns out he also gets 3 months salatravesty-11/4/2005
194it certainly is an unfortunate chapter no matter what.mopgcw-11/3/2005
193they got Davis to resign for $300K (100K/yr for three years). this all must havscaram(o)uche-11/3/2005
192Piper (dated) ACAD :Publishes ACP-104 Dopamine Receptor Agonism Study 2005-09-23mopgcw-10/28/2005
191sorry, meant that for the Arena thread. (eom)scaram(o)uche-10/18/2005
190it's up now.... no dose response, dropouts up slightly at 15 mg.scaram(o)uche-10/18/2005
189<i>Item 5. Ownership of Five Percent or Less of a Class Reporting personsscaram(o)uche-10/18/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News